In the midst of a capital raise from shareholders, Toro Energy (ASX: TOE) has continued its rush of news flow, today announcing the intersection of Nickel sulphide deposits, adding to their recently discovered Vanadium and Gold to go with their flagship resource, Uranium. As part of their exploration program into their Yandal Gold Project, located
Read More
Two months into a corporate strategy to target the lucrative Chinese market, Australian environmental management tech firm Envirosuite (ASX: EVS) is set to partner with Sailhero, a major China-based company to tackle pollution. With a market cap of USD$4.3 billion, environmental protection group Sailhero has access to 30% of the air pollution market in China
Read More
Medical cannabis producer, Cann Global (ASX: CGB) is set to expand their operations in Asia after launching a new Asian-based subsidiary, allowing them to cultivate and process cannabinoid products in South-East Asia. By commencing operation in south-east Asia, the Company is best positioned to capitalise on conditions which are ideal for outdoor growing, which may
Read More
Australian Fintech firm Wisr (ASX: WZR) has received a major boost in market confidence after securing $50 million in funding from NAB to increase debt capacity for ethical microfinance facilities. The 2-year partnership will see NAB provide an initial $50m debt warehouse program with the potential to increase to $200m. “This is an incredible result
Read More
Technology developer HeraMed (ASX: HMD) has continued its progression into the Indian market with its pregnancy monitoring devices aimed at improving engagement between pregnant women and medical professionals to improve health monitoring and early risk detection. The progress sees an extension of a Memorandum of Understanding with Indian distributors Consultus India as well as a
Read More
Biopharmaceuticals manufacturer MGC Pharmaceuticals (ASX: MXC) has seen significant uptake of its cannabinoid medications with prescriptions across Australia and the United Kingdom doubling to 800 patients through the month of October. The update comes as more medical practitioners prescribe phytocannabinoid-derived medications CannEpil®, which targets drug-resistant epilepsy, and MXP100 which is recommended for neurological disorders, inflammation
Read More
With some of the worlds largest retailers safely delivering goods by drones which are flying over people, drone safety systems company ParaZero (ASX: PRZ) has seen a notable uplift in sales for its parachute devices amongst drone manufacturers. The new orders amount to $235,000 for ParaZero but may be a sign of things to come
Read More
Carried and administered by Australian paramedics for decades, the green whistle pain reliever has been on the Australian market for years but clinical trials in Europe have now revealed Penthrox® to be a superior pain relief product than traditional treatments of morphine (IV), paracetamol, ketoprofen and NSAIDS. Marketed as Penthrox® with the key ingredient of
Read More
Prostate cancer patients could soon be in for potentially good news after clinical stage-drug development company, Noxopharm (ASX: NOX) reported interim data indicating effective anti-cancer responses from patients receiving treatment for late-stage prostate cancer. To date, the data from the study (DARRT-1) found that 80% of patients showed no further progression in their disease after
Read More
Tech newcomer Digital Wine Ventures (ASX: DW8) has hit the ground running with the signing of Casella Family Brands, Australia largest family-owned winery, as a foundation client for their one-stop-shop WineDepot platform. Launched in September 2019, WineDepot is a B2B cloud-based platform which aims to connect wine producers, distributors, importers and retailers enabling producers a
Read More
